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For the first time, the spectrofluorimetric properties of estrone (E1), 17β-estradiol (E2), 
estriol (E3), and 17α-ethinylestradiol (EE2) are studied in aqueous solutions after the 
addition of native and derivative cyclodextrins. In contrast to previous reports, the behavior 
of the systems is analysed in the absence of organic solvents able to modify the guest-host 
interaction. The significant differences between the obtained association constants with 
those reported in solvent mixtures are shown and discussed. In order to evaluate the 
influence of both the estrogen structure and the presence of cyclodextrin substituents in the 
inclusion phenomena, fluorescent and acid-base behaviors of the systems are compared and 
discussed. The interaction of estrogens with micellar media formed by selected surfactants 
is also studied. It is demonstrated that estrogen-cyclodextrin complexes in aqueous solution 
are useful for improving fluorimetric detection limits and, since cyclodextrins are non-toxic 
and mitigate most of the solubility problems which require the use of organic solvents, the 
studied complexes are excellent candidates for extraction, separation, pre-concentration and 
removal processes maintaining the principles of the green analytical chemistry. 
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Introduction 
 
Estrogens are a type of steroid hormones which play a widespread role in human 
physiology, including reproductive female functions, modulation of growth of different 
tissues, bone integrity, influence on cardiovascular apparatus, immune and nervous 
systems, and regulation of male physiology.
1
 As adverse effects, these hormones are also 
implicated in the development or progression of various types of cancer, osteoporosis, 
neurodegenerative and cardiovascular diseases, insulin resistance, lupus erythematosus, 
endometriosis, and obesity.
1
 
 The three major naturally occurring estrogens are 17β-estradiol (E2), estriol (E3), 
estrone (E1), being E2 the most potent and dominant in humans (Fig. 1). On the other hand, 
17α-ethynylestradiol (EE2, Fig. 1) is a synthetic estrogen derivative of E2 used in almost 
all modern formulations of combined oral contraceptive pills.  
 The chemical structure of estrogens, like all steroid hormones, is characterized by a 
cyclopentan-o-perhydrophenanthrene ring which is composed of three six member rings 
and one five member ring, labeled A, B, C, and D respectively (Fig. 1). Estrogens are of 
low polarity and, thus, they are capable to interact, in case of geometric compatibility, with 
the hydrophobic cavity of some cyclodextrins (CDs) to form inclusion complexes.
2
 
Estrogen-CD complexes have been used in multiple chemical areas with different purposes. 
CDs have been included in pharmaceutical formulations as solubilizer and absorption 
enhancer of estrogens,
3
 and in chromatographic and electrophoretic methods for their 
separation and determination.
4–9
 Solid-phase extractions based on complex formation with 
CDs have been applied for removing these endocrine disrupting compounds from 
environmental samples,
10
 and for sample purification in mass spectrometric analysis.
11
 CDs 
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were also used for suppressing the harmful effect of estrogens in environmental water 
through complex formation.
12
 
 So far, the association constants for estrogen-CD complexes have been measured, 
through different methods, in mixtures of water and miscible solvents.
9,13–17
 However, the 
presence of an organic solvent (e.g. alcohols) could alter the equilibrium constants between 
CDs and guest molecules.
18
 It is known that at low concentrations (e.g. 0.05–2 mol L
–1
), 
alcohols can either form a ternary complex (analyte-CD-alcohol) or act as a competing 
guest compound, since alcohols themselves are able to interact with the CD cavity.
19–22
 At 
higher concentrations (> 7 mol L
–1
), dissociation of the binary analyte-CD complex can 
occur by changes in bulk solvent hydrophobicity (non-specific solvent effects).
23
 
 The objective of this work was to study, for the first time, the influence of organized 
media in the fluorescence properties of estrogenic compounds in the absence of additional 
organic molecules able to interact with the analysed systems. Fluorescence spectroscopy, 
applied in the present experiments, possesses high sensitivity and allows to work with 
aqueous diluted estrogen solutions, without any addition of organic solvent.  
 By comparing the behavior of native CDs, we were interested in determining the 
relationship between estrogen structure and cavity size. The rationale for employing 
derivative CDs was to determine the effect of substituents at the CD entrances on estrogen 
complexation. Notable differences between the results here obtained with those reported in 
water/co-solvent mixtures were found and discussed. 
 Influence on the estrogen fluorescence properties of other factors such as the presence of 
micelles formed by surfactants, temperature and pH were also evaluated. 
 
Experimental 
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Reagents and solutions 
 
All reagents were of high-purity grade and used as received. Estrone, 17β-estradiol, estriol, 
17α-ethynylestradiol, methyl-β-cyclodextrin (M-β-CD), sulfate-β-cyclodextrin sodium salt 
(S-β-CD), Brij 35, Tween 80, heptakis(2,6-di-o-methyl)-β-cyclodextrin (DM-β-CD), and 
hexadecyltrimethylammonium bromide (HTAB) were purchased from Sigma-Aldrich 
(Milwaukee, WI, USA). Hexadecyltrimethylammonium chloride (HTAC), and (2-
hydroxyethyl)-β-cyclodextrin (HE-β-CD) were provided by Fluka (Buchs, Switzerland). 
Sodium dodecylsulfate (SDS), and methanol were obtained from Merck (Darmstadt, 
Germany). α-, β- and γ-cyclodextrins (α-CD, β-CD and γ-CD), and (2-hydroxypropyl)-β-
cyclodextrin (HP-β-CD) were acquired from Cyclolab (Budapest, Hungary). 
Methanol stock solutions of EE2, E2, E3 and E1 of about 2500 µg mL
–1
 were prepared 
and stored in dark flasks at 4 
o
C. From these solutions, more diluted methanol solutions 
(ranging from 10 to 500 µg mL
–1
) were obtained. Working aqueous solutions were 
prepared immediately before their use by taking appropriate aliquots of methanol solutions, 
evaporating the organic solvent by use of dry nitrogen and diluting with ultrapurified water 
from a Millipore system (Massachusetts, USA) to the desired concentrations. Stock 
solutions of CDs and surfactants were prepared in ultrapurified water. 
 
Apparatus 
 
Fluorescence measurements were done on an Aminco Bowman (Rochester, NY, USA) 
Series 2 luminescence spectrometer equipped with a 150W xenon lamp and using 1.00 cm 
quartz cell and slit widths of 4 nm. The excitation and emission wavelengths were 270 and 
310 nm, respectively. The temperature of the cell holder was regulated using a Lauda 
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(Frankfurt, Germany) RM6T thermostatic bath. The pH of solutions was measured with a 
Metrohm (Herisau, Switzerland) 713 pHmeter equipped with glass and Ag/AgCl reference 
electrodes. 
 
Influence of cyclodextrin and surfactant concentrations 
 
The effect of the concentration of CDs and surfactants in the fluorescence spectra of the 
estrogens was studied through the following procedure:
24
 2.00 mL of solutions in water of 
each analyte (CEE2 = CE2 = CE3 = 420 ng mL
–1
, CE1 = 1300 ng mL
–1
) were spiked with 
increasing volumes of each CD or surfactant solutions containing the same concentration of 
the corresponding estrogen, in order to avoid analyte dilution. The E1 concentration was 
about three times larger than those of the remaining estrogens, because its fluorescence 
signal is not detected at lower concentrations. The complete dissolution of E1 at this 
concentration was corroborated by UV-visible absorption measurements. After each 
addition, the fluorescence spectrum was read. This procedure could be applied even with β-
CD, the less soluble CD, because the concentrations of the CD titrating solutions were 
about 6 – 8×10
–3 
mol L
–1
, below the β-CD aqueous solubility (0.01 mol L
–1
). It is necessary 
to remark that inclusion complexes are rapidly formed, as was verified by the constancy of 
the obtained fluorescence signal after each addition of CD solution. 
 With the purpose of obtaining the blank signals, a similar procedure was also performed 
in the absence of analyte. Finally, blank signals were subtracted from the corresponding 
spectra and the plot of the corrected fluorescence intensity at a maximum as a function of 
either CD or surfactant concentration was obtained. 
 
Influence of the pH 
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The changes in the fluorescence intensity of EE2, E2, E3 and E1, and their β- and DM-β-
CD complexes as a function of pH were studied by the following procedure: to 50 mL 
stirred hydrochloric acid solution (CHCl ca. 0.01 mol L
–1
) of the estrogens or their CD 
complexes, NaOH solution (0.05–1 mol L
–1
) was added in small increments (0.01–
0.05 mL). For each pH point a known aliquot of solution was extracted and the 
fluorescence spectrum was read. The initial concentrations in the reaction vessel of EE2, E2 
and E3 were 420 ng mL
–1
, and the initial concentration of E1 was 1300 ng mL
–1
. In the 
experiments with CDs, their concentrations were kept at 5×10
–4
 mol L
–1
. The temperature 
was maintained at 20°C. The measurements were performed in duplicate. The profiles of 
fluorescence at the wavelength of the emission maxima vs. pH were used to calculate the 
deprotonation constant values of the estrogens in the excited state, both in the presence and 
in the absence of the selected CDs. These calculations were performed with the aid of the 
PKFIT program,
25
 which is based on a least-squares procedure and can be obtained from 
the authors on request. 
 
Results and discussion 
 
Fluorescence spectra 
 
Fig. 2A shows the excitation fluorescence spectra for the studied estrogens, with maxima at 
about 220 and 278 nm, and the emission spectra with maxima at about 310 nm. Although 
E2, E3 and EE2 are relatively more fluorescent than E1, all signals have low intensity. 
Indeed, Raman bands from the solvent, which appear near those of the analytes signals, are 
clearly visualized. This fact represents a problem when selecting excitation and emission 
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wavelengths for analytical purposes. In fact, in order to avoid the Raman band, 270 nm was 
selected as excitation wavelength in the present work. The signal intensities of compounds 
with low native fluorescence could be increased, for example, through the use of organized 
media. The addition of selected CDs and micelles to estrogens water solutions results in an 
increase in fluorescence intensity of different magnitude depending on the evaluated system 
(Figs. 2B-D).  
 
Cyclodextrins effect in aqueous solution 
 
These experiments were conducted at neutral pH, where the fluorescence intensity of each 
system is the highest and estrogens remain in their neutral structures (see below), which are 
optimal for inclusion complex formation with CDs.
2
 
 The investigated CDs involved the three major cyclodextrins: α-, β-, and γ-CDs 
(constituted by six, seven, and eight glucose units, respectively), and the β-CD derivatives 
S-β-, HE-β-, HP-β-, M-β- and DM-β-CDs (Fig. 1).  
 Fig. 3 displays the intensities of the fluorescence emissions of each studied estrogen at 
different concentrations of selected CDs. Changes in fluorescence with the CD 
concentration can be attributed to the formation of inclusion complexes between the 
analytes and CD. Assuming 1:1 complex stoichiometries, equal extinction coefficients of 
the free and complexed substrate (the absorption spectrum of estrogens was not 
significantly modified by CDs) and free CD concentration approximately equal to its 
analytical concentration (CD is in large excess with respect to the guest), the following 
equations can be written: 
])[Ø ][Ø( CEbF CE +=          (1) 
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EECbF Ø0 =            (2) 
where F and F0 are the observed fluorescence intensity in the presence and absence of CD, 
b is a constant depending on the experimental conditions, ØE and ØC are the fluorescence 
quantum yields of the free and complexed estrogens, respectively, and [E] and [C] are the 
free concentrations of estrogen and complex, respectively. From these equations, the 
following expression is obtained:
26,27 
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where K is the corresponding association constant. The K values obtained by a non-linear 
lest-square procedure from Eq. 3 are reported in Table 1. From the same calculation, 
fluorescence quantum yield ratios (ØC/ ØE) are also derived (Table 2). The good fit of each 
plot (Fig. 3) supports the existence of complexes with 1:1 stoichiometric ratio. The same 
stoichiometry was previously reported for estrogen-CD complexes in water/co-solvent 
samples.
13–17
  
 For comparison, association constants were also estimated through a relation analogous 
to the Benesi-Hildebrand equation:
16
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where ∆F is the difference between the fluorescence intensity in the presence and in the 
absence of CD, and εC and εE are the molar absorptivities with and without CD. The good 
fit of this linear regression (Fig. 4 shows selected examples) does also suggest the existence 
of 1:1 complexes. Table 1 summarizes the calculated association constants applying both 
non-linear and linear regressions. As can be appreciated, both procedures are in very good 
agreement. Further, a rapid inspection of Table 1 allows concluding that the interaction 
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between the studied estrogens and some CDs in aqueous medium is very strong. This fact 
could be explained on the basis of the high hydrophobicity of estrogens, which also justifies 
the differences found with the values reported in the presence of variable percentages of 
organic solvents (see below). 
Among the three native CDs, α-CD does not appreciably modify the fluorescence 
properties of any of the studied estrogens, a slight increase of fluorescence is verified in the 
presence of γ-CD in most systems, and β-CD appears to have the best cavity for inclusion 
complex formation. These results suggest that the cavity size of β-CD (which is larger than 
α-CD and smaller than γ-CD) produces a tighter complex structure, efficient for protection 
towards non-radiative decay processes occurring in the bulk solution.  
It can be noted in Table 1 that the complex formed by γ-CD and E1 could not be 
detected using the present methodology, possibly because the changes in fluorescence 
intensity with the addition of this CD are not sensitive enough to detect it and, therefore, the 
related association constant could not calculated. 
In addition to the cavity size, the presence of substituents in the CD molecule can 
contribute to the complex formation and, therefore, different functionalised β-CDs were 
investigated. Among the β-CD derivatives, S-β-CD does not significantly modify the 
fluorescence intensity of the estrogen systems. Apparently, the polarity of this host 
molecule would prevent the association with guests of low polarity such as the analised 
estrogens. Both 2-HE and 2-HP-β-CDs display a positive effect toward the complex 
formation and o-methyl substituents, such as those present in M- and DM-β-CDs, showed 
to be the most efficient. The analysis of molecular models of these complexes suggests that 
oxygen atoms in the substituent chains of 2-HE, 2-HP, M-, DM-β-CDs are approximately 
at the same position. Therefore, the difference in the stability of the corresponding 
Page 9 of 34 Analyst
10 
 
inclusion complexes could be explained on the basis of a possible inductive effect of 
methyl groups in the o-methyl derivatives on the oxygen lone electron pairs, with the 
concomitant formation of stronger hydrogen bonds with the guest molecule. 
O-methyl β-CD derivatives, with relative quantum yields around 2 (Table 2), produce 
the best fluorescence enhancement and, consequently, would be the most adequate for 
quantitative analysis. 
Comparing the relative stability of the formed complexes, the following order  e justified 
focusing on the hydrophobicity of the guest molecule since, in general, the more 
hydrophobic the analyte, the more stable is its CD complex in aqueous solution.
28
 
However, the fact that E3 (with the lowest octanol-water partition coefficient, Table 3)
29
 
forms complexes nearly as stable as those of E2, and more stable than those of E1, cannot 
be explained on the basis of its hydrophobicity. Certainly, in addition to the van der Walls 
and hydrophobic forces which favor the inclusion in the CD cavity of the virtually planar 
cyclopentan-o-perhydrophenanthrene nucleus (Fig. 1), the two OH groups in the D-ring of 
E3 are able to form hydrogen bonds with the host molecule and, therefore, play a key role 
in the complex formation process. In accordance with the conclusion of Yañez et al,
17
 the 
differences among the association constant values suggest that inclusion may take place 
through the insertion of the D-ring of these estrogens into the CD cavities. 
On the other hand, the structural feature of the A-ring of the steroid molecule has also a 
great influence on the stability of the inclusion complexes. Moon et al., in their work about 
solid-phase extraction of steroids with an entrapped-β-CD polymer, demonstrated that 
hydroxylated estrogens were more effectively captured by the β-CD polymer than other 
tested steroids, possibly due to the hydrogen bonding between the estrogen phenolic 
hydroxyl and the external hydroxyl groups of β-CD.
11
 In our case, all evaluated estrogens 
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have the same A-ring structure. Hence, the higher stability of the complexes formed by 
some derivative β-CDs would be given by the link of the phenolic hydroxyl with the 
substituent groups, as will be demonstrated through the acid-base properties of the four 
estrogens in the presence of CDs (see below). 
 
Acid-base behaviour in the absence and in the presence of CDs 
 
Estrogens are very weak acids with pKa values in the range 10–10.5 (Table 3).
30–32
 Here, 
the acid-base behaviour of EE2, E2, E3 and E1 in the excited-state was investigated by 
spectrofluorimetric titrations. Fig. 5A shows the experimental profiles of each estrogen as a 
function of pH at the emission maximum. In all systems, fluorescence intensity is highest 
and remains almost constant in the pH range 2–9.5 and decreases at larger pH values. From 
these profiles, values of deprotonation constants for the phenolic groups in the excited state 
could be obtained (Table 3). As can be seen, the estimated values are similar to those 
reported in the ground state. In order to conclude from these results, information for the 
Förster cycle was analysed assuming equal entropies of protonation in the ground and 
electronically excited states.
27,33 
The relevant equation is:  
pKa – pKa
*
 = k  (ν a –ν b)         (5) 
where k is a constant which includes the Avogadro´s number, the Planck´s constant, the 
speed of light, the universal gas constant, the absolute temperature and the logarithm factor 
conversion, and ν  are the wavenumbers corresponding to the transitions from the acid to 
the excited acid form (ν a) and from the conjugate base to the excited conjugate base form 
(ν b). In the studied systems, no differences between ν a and ν b were verified, suggesting 
that the process probed by the fluorescence-pH study does also correspond to the 
deprotonation in the ground-state. 
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By comparing the pKa values of estrogens in both the presence and absence of CDs, 
conclusions about the interaction of the phenolic hydroxyl of the A ring with the CD 
molecule can be inferred. Fluorimetric titrations were performed with both β- and DM-β-
CDs (Fig. 5B and 5C), which are the most efficient native and derivative CDs, respectively.  
The high constant values of the complexes formed by these CDs provide a high 
percentage of complexed analyte ensuring that the measured pKa values correspond to the 
complexed analyte rather than to the free analyte. For example, for the E2-β-CD and E2-
DM-β-CD systems, using the association constants given in Table 1, and considering that in 
a typical experiment analytical concentrations of CD and E2 are equal to 5×10
–4
 and 
1.5×10
–6 
mol L
–1
, the percentages of formed complex for β- and DM-β-CDs are 95 and 99 
%, respectively. Thus, the measured deprotonation constants involve a very significant 
contribution from these complexes, and safer conclusions from the acid–base behavior can 
be elaborated.  
 The pKa values in the presence of β- and DM-β-CDs (Table 3) are slightly larger than 
those obtained in their absence, and the differences are more marked with the latter CD. 
Consequently, an interaction between the acidic group of each estrogen molecule and an 
external hydroxyl group in β-CD and the methyl moiety in DM-β-CD is verified. These 
results strongly suggest that the contribution of the phenolic hydroxyl of the estrogen on the 
stability of the inclusion CD complexes is significant. The increase in the pKa value when 
the analyte is included in the cavity of the CD has been observed in similar systems formed 
by indole, naphthol and phenol derivatives.
27
 
 
CD inclusion complexes in water/co-solvent mixtures 
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Due to the low water solubility of estrogens (Table 3),
34–36
 all previously reported 
association constants for estrogen-CD complexes correspond to values measured in the 
presence of variable amounts of organic solvents, such as methanol, ethanol and acetonitrile 
(Table 4). As indicated above, under fluorimetric conditions the studied compounds were 
found to be soluble in the analysed range of pH (2-12) and, therefore, in the present work 
determinations were performed in aqueous solution.  
 Nevertheless, the association constant of the model E2-β-CD complex was 
fluorimetrically calculated in different methanol-water mixtures for comparison purposes 
(Table 4). It should be noticed that, in contrast to Tables 1 and 3, Table 4 shows the 
uncertainties expressed as standard deviations rather than confidence intervals for better 
comparison with literature values. The obtained constant values (4.3×10
4
, 2.3×10
4
, 1.6×10
4
 
and 4.8×10
3
 mol
–1 
L
 
for 0, 5, 10 and 20 % of methanol) decrease with increasing methanol 
content. A ca. five-fold decrease in the association constant in going from pure water to 20 
% methanol is corroborated. The presence of the organic solvent certainly modifies the 
affinity of the estrogen by the CD cavity. Reasonable agreement is observed between our 
results in the presence of 20 % of methanol (K = 4.8×10
3
 mol
–1
L) and the previously 
reported values for this system under the same solvent composition: 6.8×10
3
 mol
–1
L (ref. 
15) and 3.7×10
3
 mol
–1
L
 
(ref. 16). 
Table 4 also includes reported association constants for some estrogen-CD complexes in 
other experimental conditions and using various determination methods. In all reported 
water/co-solvent systems, the constant values are lower than those obtained in water. The 
relative order of the association constants in water/co-solvent systems at low co-solvent 
concentrations is EE2>E2>E3>E1, similar to the order found in aqueous systems.
15,16
 
However, in β-CD systems and at higher amounts of organic solvent (e.g. 30 and 45 %), 
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more hydrophobic subtrates tend to leave the CD cavity and, in those cases, EE2 complexes 
are less stable than the corresponding E2 ones. 
 Another difference between aqueous and water/co-solvent systems is the relative 
stability of the complexes formed by β- and γ-CDs. In the former cases, β-CD complexes 
are more stable than γ-CD ones. A similar conclusion was obtained by Oishi et al. in 10 % 
methanol solutions.
12
 Nevertheless, at higher methanol ratios the order is reversed (Table 4) 
possibly due to the better affinity of the alcohol for the β-CD cavity, displacing the analyte 
from the host molecule. Indeed, Wu et al. demonstrated that the association constants of γ-
CD with alcohols are about one order of magnitude smaller than those of β-CD.
37
 
 Estrogen-CD association constants determined by capillary electrophoresis using SDS in 
the run buffer (Table 4) cannot be compared with those obtained here. In this case, the 
presence of micelles in the run buffer is necessary for differentiating the mobility of 
analytes while adding neutral CDs, but the estrogen-micelle interaction is strong and 
competes with the CD inclusion processes. Thus, the obtained constant values are 
significantly lower than those obtained in water, and the affinity of the estrogens towards a 
particular CD type also changes. 
 
Micellar-enhanced fluorescence 
 
The effect produced by micelles on the fluorescence intensity of estrogens was studied by 
keeping constant the concentration of each analyte and increasing the concentrations of 
selected surfactants (Fig. 6). For ensuring the micelle formation, the maximum 
concentrations of the evaluated surfactants were higher than the corresponding critical 
micelle concentrations (CMC).
38
 Those surfactants with large methylene chains showed to 
be adequate in terms of fluorescence enhancement, probably due to the better interaction of 
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this group with the analytes. The maximum intensities reached, even with the best systems 
formed by HTAC, were lower than that obtained with several studied CDs. Apparently, 
CDs offer a better shielding environment to the excited estrogen molecules from non-
radiative pathways, in accordance with the high stability constant values calculated for the 
corresponding inclusion complexes.  
 
Temperature effect 
 
The influence of the temperature on the fluorescence emission of E2 in the presence of 
DM-β-CD, taken as a model system, was evaluated. The experiment showed that a 
temperature decrease does not significantly improve the fluorescence intensity. For 
instance, if the experiment is conducted at 5 °C, the fluorescence increases only about 3 % 
of the original value at 20 °C. Therefore, no efforts were made to keep a low working 
temperature. 
 
Analytical Parameters 
 
The linear dependence between the fluorescence response and the estrogens concentration 
was investigated by building calibration curves under optimum conditions. According to 
the above results, the construction of the curves was carried out in the presence of 5×10
–4
 
mol L
–1
 DM-β-CD at 20 °C and neutral pH. In order to evaluate the effect of the selected 
λexc on the calibration parameters, two curves using either 222 or 270 nm as excitation 
wavelength were constructed. While the concentration of DM-β-CD was kept constant in 
the calibration samples, the concentrations of E2, E3 and EE2 were varied from 0 to 200 ng 
mL
–1
, and the concentration of E1 was varied from 0 to 1000 ng mL
–1
. These samples were 
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prepared by suitable dilution of a stock water solution of each estrogen and CD. It is 
necessary to point out that although no attempts were made to establish the upper 
concentration of the linear range, linear relationship between signal and concentration was 
verified at least until 1500 ng mL
–1
 in all systems by applying the F test recommended by 
IUPAC
39
. However, we decided to work with a more restricted concentration range, since 
the goal is to detect low concentrations of these compounds. 
Table 5 summarizes the obtained results. For comparison, statistical parameters obtained 
in the absence of the selected CD were also included in this table. 
In comparing the results using different maximum excitation wavelengths, one may note 
that the difference is not significant. The use of the selected organized medium allows to 
obtain detection limits in the range 2–4 ng mL
–1
 for E2, E3 and EE2, with relative standard 
deviations (n = 5) of 1.0–1.8 % for 50 ng mL
–1
. As expected, for the less fluorescent E1 
system poorer values were obtained. When the calibration in the absence of CD is carried 
out, the limits of detection and quantification increase and the analytical sensitivities 
decrease, highlighting the advantage of using DM-β-CD in the determinations.  
Taken into account that the evaluated procedure involves direct measurements without 
using organic solvents and employing unsophisticated instrumental, the attained limits of 
detection in the presence of DM-β-CD are very suitable. Limits of detection at part-per-
billion levels, as those here determined, for different estrogens in environmental and fishery 
samples have been found, for example, using excitation-emission fluorescence matrices 
coupled to second-order calibration,
40
 molecularly imprinted solid-phase extraction with 
HPLC and fluorescence detection,
41
 and through a flow-injection chemiluminescence 
method.
42
 Limits of detection at part-per-trillion levels or lower have been reported for the 
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determination of these hormones, but using different pretreatments involving extraction and 
pre-concentration and, sometimes, derivatization steps.
43–46
 
 
Conclusions 
 
The results of this study contribute to the understanding of the interaction of organized 
media and estrogens without the influence of third parties.  
 The poor fluorescence intensity of estrogens in water is significantly enhanced by β-
cyclodextrin and its hydroxyethyl, hydroxypropyl and o-methyl derivatives. The increases 
in fluorescence intensity with increasing concentrations of cyclodextrin were used to 
evaluate both the stability and stoichiometry of the formed complexes. The high constant 
association values for the 1:1 complexes, in the range 5×10
3
–5×10
5
 mol
–1
 L, demonstrate 
that the interaction of these hydrophobic molecules with the cyclodextrin nanocavity is 
extremely strong. The relative stability of the formed complexes could be explained on the 
basis of both hydrophobicity and specific hydrogen bonds of the guest molecule with the 
cyclodextrin, allowing to conclude about structural issues. 
 The acidity constants of estrogens in both the presence and absence of cyclodextrins 
allows inferring the interaction of the phenolic hydroxyl of the A ring of the estrogens and 
the external groups of the CDs. 
 The presence of organic solvents in the reaction medium decreases the affinity of the 
estrogen by the cyclodextrin cavity in a magnitude that depends on the percentage of 
organic solvent present. Micellar systems formed by surfactants with large methylene 
chains also increase the fluorescence of the studied estrogen, but not as significantly as in 
some cyclodextrin systems. 
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 The use of heptakis(2,6-di-o-methyl)-β-cyclodextrin could be a suitable strategy to 
determine poorly fluorescent estrogens at part-per-billion levels, without using either 
derivatization reactions or toxic organic solvents. 
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Table 1 Association constant values for estrogen-cyclodextrin complexes obtained from non-
linear regression (K) and from the Benesi-Hildebrand type equation (KB-H)
a
 
 EE2 E2 E3 E1 
 log K log KB-H log K log KB-H log K log KB-H log K log KB-H 
γ-CD 4.3 ± 0.1 4.3 ± 0.1 4.2 ± 0.1 4.26 ± 0.05 4.00 ± 0.07 4.00 ± 0.08 
b b 
β-CD 4.95 ± 0.01 4.9 ± 0.1 4.63 ± 0.07 4.63 ± 0.02 4.52 ± 0.06 4.51 ± 0.03 3.9 ± 0.3
 
3.6 ± 0.3 
HE-β-CD 4.97 ± 0.09 4.96 ± 0.06 4.68 ± 0.1 4.65 ± 0.06 4.5 ± 0.1 4.48 ± 0.08 3.7 ± 0.2 3.88 ± 0.07 
HP-β-CD 5.05 ± 0.06 5.05 ± 0.03 4.83 ± 0.06 4.83 ± 0.04 4.67 ± 0.06 4.66 ± 0.02 3.70 ± 0.08 3.7 ± 0.1 
M-β-CD 5.4 ± 0.1 5.4 ± 0.1 4.99 ± 0.08 4.99 ± 0.06 4.70 ± 0.04 4.68 ± 0.04 3.9 ± 0.2 4.0 ± 0.2 
DM-β-CD 5.7 ± 0.2 5.7 ± 0.2 5.2 ± 0.2 5.2 ± 0.2 5.11 ± 0.01 5.09 ± 0.09 4.1 ± 0.3 4.2 ± 0.2 
a
 Confidence intervals were calculated as: SD×Student t value, where SD is the standard deviation 
and t is taken at 95 % of confidence and (n–2) degrees of freedom. The number of data points (n) 
in each experiment varied between 7 and 14.
 b
 See text. 
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Table 2 Fluorescent quantum yield ratios between complexed (ØC) and free (ØE)  analyte
a
 
 EE2 E2 E3 E1 
 ØC/ ØE ØC/ ØE ØC/ ØE ØC/ ØE 
γ-CD 1.36(1) 1.56(1) 1.43(1) 
b 
β-CD 1.78(1) 1.84(1) 1.74(1) 1.77(4) 
HE-β-CD 1.73(1) 1.83(1) 1.81(1) 2.17(5) 
HP-β-CD 1.74(1) 1.95(1) 1.84(1) 2.47(4) 
M-β-CD 1.80(1) 1.91(1) 1.91(1) 2.02(5) 
DM-β-CD 2.07(1) 1.87(1) 2.04(1) 1.96(5) 
a
 Standard deviations in the last significant figure are given between parentheses.
  b
 See text. 
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Table 3  Octanol-water partition coefficient (KOW), deprotonation constant (pKa), and aqueous 
solubility (S) for selected estrogens
a 
  EE2  E2  E3  E1  Ref. 
log KOW  4.15  3.94  2.81  3.43  29 
  
 
 
 
 
 
 
  
 
pKa  10.21
 
 10.23
 
 10.05
 
 
  
30 
  10.40
 
 10.46
 
   10.34  31 
  
 
   10.4  
  
32 
 
 10.3 ± 0.1  10.1 ± 0.1   10.4 ± 0.1  10.3 ± 0.1 
 
This work 
  10.4 ± 0.1
b 
 10.80 ± 0.06
b 
 10.6 ± 0.1
b 
 10.60 ± 0.04
b  
This work 
  10.87 ± 0.06
c 
 11.16 ± 0.06
c 
 11.30 ± 0.04
c 
 10.9 ± 0.1
c 
 This work 
           
S (mg L
–1
)  4.8  13  13  13  29 
  9.7  3.9    0.8  31 
  19.1
 
 3.85
 
 30.2
 
   34 
  9.20
d 
 1.51
d 
   1.30
d 
 35 
  3.1
e 
 3.1
e 
   2.1
e 
 36 
a
 Confidence intervals were calculated as: SD×Student t value, where SD is the standard 
deviation and t is taken at 95 % of confidence and (n–2) degrees of freedom. The number of 
experimental pH values (n) for each pKa determination varied between 16 and 23. 
b 
In the 
presence of β-CD, 20
 o
C.
 c
 In the presence of DM-β-CD, 20
 o
C. 
d
 25 
o
C, pH 7. 
e
 23 
 o
C. 
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Table 4 Association constant values for complexes formed by estrogens and cyclodextrins in different 
experimental conditions
a 
Experimental conditions Method  EE2  E2  E3  E1  Ref. 
   β-CD   
W, 20 °C
 
F  9.0(1)×10
4 
 4.3(3)×10
4 
 3.3(2)×10
4 
 
 
 This work 
MeOH/W(5/95 v/v), 20 °C
 
F    2.3(1)×10
4 
     This work 
MeOH/W(10/90 v/v), 20 °C F    1.60(4)×10
4 
     This work 
MeOH/W(20/80 v/v), 20 °C
 
F    4.8(3)×10
3 
     This work 
MeOH/W(20/80 v/v), 35 °C F  5.6(5)×10
3 
 3.7(7)×10
3 
 3.2(4)×10
3 
   16 
MeOH/W(20/80 v/v), 35 °C HPLC  7.6(8)×10
3 
 6.8(7)×10
3 
 4.7(4)×10
3 
 3.1(6) ×10
3 
 15 
MeOH/W(45/55 v/v), 35 °C HPLC  2.71(9)×10
2 
 4.0(1)×10
2 
 2.23(2)×10
2 
 2.38(9)×10
2 
 13 
MeOH/W(45/55 v/v), 30 °C H-D
b 
 364  465  300  267  14 
ACN/W(30/70 v/v), 30°C H-D
b 
 125  191  152  92  14 
ACN/phosphate buffer 
(35/65 v/v, pH 5), 25 °C 
DPV    1.1(1)×10
2 
   6.0(8)×10
1 
 17 
ACN/phosphate buffer 
(35:65 v/v, pH 5), 25 °C 
HPLC    2.67(6)×10
2 
   8.9(2)×10
1 
 17 
EtOH/phosphate buffer 
(25/75 v/v, pH 5), 25 °C 
DPV    2.0(3)×10
2 
   1.4(2)×10
2 
 17 
Na2PO4H/SDS, 20 °C CE  1.3(8)×10
2 
 7(7)×10
1 
 4(1)×10
1 
   9 
   γ-CD   
W, 20 °C F  2.2(3)×10
4 
 1.6(2)×10
4 
 1.01(7)×10
4 
 
 
 This work 
MeOH/W(20/80 v/v), 35 °C
 
F  9(1)×10
3 
 6.3(3)×10
3 
 3.2(6)×10
3 
   16 
MeOH/W(20:80 v/v), 35 °C HPLC  1.1(1)×10
4 
 7.1(4)×10
3 
 3.2(4)×10
3 
 2.6(2)×10
3 
 15 
MeOH/W(45/55 v/v), 30 °C H-D
b 
 910  882  523  352  14 
ACN/W(30/70 v/v), 30°C H-D
b 
 414  384  313  182  14 
Na2PO4H/SDS, 20 °C CE  1.87(3)×10
3 
 1.23(2)×10
3 
 1.28(1)×10
3 
 6.4(2)×10
2 
 9 
   HP-β-CD   
W, 20 °C F  7.1(2)×10
4 
 3.9(2)×10
4 
 3.7(2)×10
4 
 4.9(4)×10
3 
 This work 
Na2PO4H/SDS, 20 °C CE  1.0(3)×10
2 
 1.0(3)×10
2 
 1.1(2)×10
2 
 6(3)×10
1 
 9 
a
 Standard deviations in the last significant figure of equilibrium constants are given between parentheses. 
b
Hummel-Dreyer method.
47 
Abbreviations: ACN, acetonitrile; CE, capillary electrophoresis; DPV, differential 
pulse voltammetry; EtOH, ethanol; F, fluorimetric; HPLC, high-performance liquid chromatography; MeOH, 
methanol; SDS, sodium dodecylsulfate; W, water. 
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Table 5 Calibration results for estrogens in the absence and in the presence of DM-β-CD
a
 
 EE2  E2  E3  E1 
 λexc  λexc  λexc  λexc 
 222 nm 270 nm  222 nm 270 nm  222 nm 270 nm  222 nm 270 nm 
 Without DM-β-CD 
CR
b 
(ng mL
–1
) 
 
0–200 0–200  0–200 0–200  0–200 0–200  0–1000 0–1000 
R
c 
0.9997 0.9989  0.9989 0.9985  0.9991 0.9981  0.9993 0.9990 
a
d 
2.9(5) 4.3(6)  4.3(7) 3.5(8)  3.7(9) 3.5(5)  1.2(2) 1.6(2) 
b
e 
0.542(5) 0.405(5)  0.689(7) 0.432(7)  0.574(8) 0.367(4)  0.0154(3) 0.0120(3) 
γ
f 
(ng
–1
 mL) 0.36 0.25  0.35 0.19  0.22 0.27  0.03 0.03 
LOD
g 
(ng mL
–1
) 6.5 9.3  6.8 13  11 8.7  89 88 
LOQ
h
 (ng mL
–1
) 19 27  19 36  31 25  258 255 
RSD
i
 (%) 2.5 4.3  3.5 6.2  5.1 4.3  13 13 
 With DM-β-CD 
CR
 
(ng mL
–1
) 
 
0–200 0–200  0–200 0–200  0–200 0–200  0–1000 0–1000 
R
 
0.9998 0.9996  0.9999 0.9998  0.9998 0.9997  0.9979 0.9988 
A
 
12.8(4) 6.8(2)  13.7(3) 7.5(2)  14.6(5) 7.7(2)  12.0(3) 7.7(1) 
B
 
0.761(4) 0.324(2)  0.984(3) 0.422(2)  0.823(4) 0.348(2)  0.0316(5) 0.013(1) 
γ
 
(ng
–1
 mL) 0.64 0.53  1.0 0.78  0.67 0.64  0.04 0.05 
LOD
 
(ng mL
–1
) 3.7 4.4  2.3 3.0  3.5 3.7  59 44 
LOQ (ng mL
–1
) 11 13  6.6 8.8  10 11  170 128 
RSD (%) 1.4 1.8  1.0 1.4  1.6 1.6  14 13 
a
 The number of data for each calibration curve corresponds to seven different concentration 
levels, with three replicates for each level (n =/21). 
b 
Calibration range. 
c 
Correlation coefficient. 
d
 
Intercept (standard deviation within parentheses). 
e
 Slope (standard deviation within parentheses). 
This value is the calibration sensitivity according to IUPAC.
39
 
f
 Analytical sensitivity: γ =/b/SS, 
where SS is the standard deviation of the regression residuals.
48
. 
g
 Limit of detection calculated 
according to ref. 49 using 0.05 as assurance probabilities. 
h
 Limit of quantification calculated as 
LOD × (10/3.3). 
i
 Relative standard deviation. In all cases five replicates were measured. CDM-β-CD 
= 5×10
–4
 mol L
–1
, CEE2 = CE2 = CE3 =/50 ng mL
–1
; CE1 = 100 ng mL
–1
). 
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Figure captions 
 
Fig. 1 Estrogen structures and schematic representation of derivative β-cyclodextrins. 
 
Fig. 2 Excitation and emission fluorescence spectra for E2 (black), E3 (red), EE2 (blue) and E1 (green) 
in aqueous solution (A), in the presence of β-CD (B), in the presence of DM-β-CD (C), and in micellar 
medium given by HTAC. The gray lines in all plots are the corresponding blanks and asterisks mark 
the Raman signals. CE2 = CE3 = CEE2 = 420 ng  mL
–1
, CE1 = 1300 ng mL
–1
; Cβ-CD = CDM-β-CD = 5×10
-4
 
mol L
–1
; CHTAC = 7×10
–3
 mol L
–1
. 
 
Fig. 3 Effect of cyclodextrins, as indicated, in the fluorescence emission of E2 (black), E3 (red), EE2 
(blue) and E1 (green). λexc = 270 nm; CE2 = CE3 = CEE2 = 420 ng mL
–1
; CE1 =  1300 ng mL
–1
; t = 20 °C. 
The left vertical axis corresponds to E2, E3 and EE2; the rigth vertical axis to E1. Additional data (not 
shown) at higher CD concentrations were measured. Each point was background-corrected. Solid lines 
are the non-linear fit to the data. 
 
Fig. 4 Benesi-Hildebrand type plots for E2 (black) and E3 (red) –β-CD complexes. Solid lines are the 
linear fit to the data. 
 
Fig. 5 Experimental fluorescence values vs. pH for E2 (black), E3 (red), EE2 (blue) and E1 (green) in 
the absence of organized media (A), in the presence of β-CD (B), and in the presence of DM-β-CD (C). 
λexc = 270 nm; CE2 = CE3 = CEE2 = 420 ng mL
–1
; CE1 = 1300 ng mL
–1
; Cβ-CD = CDM-β-CD = 5×10
–4
  mol 
L
–1
; t = 20 °C. Solid lines are the non-linear fit to the data. 
 
Fig. 6 Effect of surfactants, as indicated, in the fluorescence emission of E2 (black line), E3 (red line), 
EE2 (blue line) and E1 (green line). Critical micellar concentration (CMC) corresponding to each 
system are indicated (ref. 37). λexc = 270 nm; CE2 = CE3 = CEE2 = 420 ng mL
–1
; CE1 = 1300 ng mL
–1
; t = 
20 °C. Each point was corrected with the corresponding background. 
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The strong interaction between estrogens and selected cyclodextrins in the absence of organic 
solvents is demonstrated through a spectrofluorimetric study. The formed complexes would 
be of interest in analytical areas based on green chemicals. 
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